Respiratory
Boehringer Ingelheim has over 95 years of heritage in respiratory disease. Since 1921 we have emerged as a leader in this disease area, having launched several treatments in a range of respiratory conditions including asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF) and lung cancer. Our focus is on improving the quality of life of patients suffering from debilitating respiratory diseases and enabling them to maintain a more independent life.
Systemic sclerosis (SSc) is a disfiguring, disabling and potentially fatal rare disease that causes scarring of the skin (scleroderma), lungs (SSc-ILD) and other organs. Worldwide it is estimated that over two million people have systemic sclerosis and it affects mostly women in the prime of their lives, between 25 and 55 years of age. Systemic sclerosis is a complex rare disease with a variable course. It presents with a range of symptoms involving several different organs; this means it is difficult to recognize and this can delay early and accurate diagnosis.
-
-
-
-
-
Rare Disease Day 2019
-
A Unique Bond: there’s nothing like it
Scleroderma
It's not easy to live with systemic sclerosis, but the remarkable relationship Anna has built with Csenge has helped her realise her capabilities.
-
Scleroderma
In 2009 Anna was diagnosed with scleroderma. For her, however, the disease is no reason to give up. On the contrary.
-
More Than Systemic Sclerosis - The Inside Story
Scleroderma
Portrait collection which showcases the unique and inspiring stories of people living with systemic sclerosis, also known as scleroderma
-
-
Scleroderma
A hub of knowledge, advice and support for those whose lives have been touched by scleroderma.
-
Professor Denton
Scleroderma
In this new video listen to consulant rheumatlogist Professor Denton discuss his experience diagnosing systemic sclerosis
-
Annelise’s story
Scleroderma
Watch Annelise, a systemic sclerosis patient, talk about how she coped with her diagnosis
-
-
Let’s meet someone living with systemic sclerosis.
Scleroderma